Filing Flows › Tenaya Therapeutics (TNYA) › Stock forecast & fair value
Tenaya Therapeutics (TNYA) stock forecast and price target
Tenaya Therapeutics (TNYA) trades at $0.36. 5 analysts' median price target is $3.00 (+733%), from $2.00 to $5.00.
Tenaya Therapeutics' latest quarter
Tenaya Therapeutics, Q3 2026: revenue $1.7M, net loss $18.9M, operating cash flow −$17.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for TNYA stock?
The median of 5 analysts' 12-month targets is $3.00, +733% from $0.36; the range is $2.00 to $5.00. The average rating is none.
Does Tenaya Therapeutics usually beat earnings estimates?
It beat the consensus EPS estimate in 60% of the quarters on record.
Is TNYA stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.